Skip to main content
WO

Westlake Omics 西湖欧米

Westlake Omics develops AI-powered proteomics technology that enhances the precision of tumor diagnostics through quantitative and spatial proteomics methods. By providing reliable diagnostic tools, the company aims to improve patient outcomes in clinical settings by enabling accurate tumor characterization.

杭州市, 中国Founded 202018100+ followers
Updated 4 months ago

Funding

Funding not disclosed

+6
Funding rounds are not available yet.

Founders

Product

Problem

Current methods for tumor diagnostics often lack the precision needed for accurate characterization, hindering effective treatment planning and optimal patient outcomes. Traditional proteomics techniques may not fully capture the spatial heterogeneity and complexity of tumor microenvironments.

Solution

Westlake Omics offers AI-powered proteomics services and products that enhance tumor diagnostics through quantitative and spatial proteomics. Their technology decodes the micro-world of life by leveraging technological innovations in proteomics and multimodal big data technology. The company's services include quantitative proteomics, modification proteomics, multi-omics analysis, targeted quantification, metabolomics, and AI-empowered proteomics data analysis. Westlake Omics also provides a cloud platform and various kits, including the FAXP™ kit for spatial proteomics and super-resolution imaging, and the OmniProt™ kit for low-abundance protein enrichment.

Target Audience

Westlake Omics serves universities, research institutes, hospitals, and pharmaceutical companies involved in precision medicine and drug research and development.

Features

  • FAXP™ kit enables 512-fold volume expansion in tissue samples, achieving 8-fold lateral expansion and 125-micron lateral resolution for spatial proteomics.
  • OmniProt™ kit enriches low-abundance proteins from plasma/serum samples.
  • AI-empowered proteomics platform for advanced data analysis and interpretation.
  • Quantitative proteomics services using TMT (Tandem Mass Tag) technology.
  • Multi-omics analysis integrating proteomics with genomics, transcriptomics, and metabolomics data.
  • Bioinformation services including machine learning and time-series analysis.
  • Westlake Omics Cloud Platform for data management and analysis.
This profile is AI-generated and may contain inaccuracies.